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Increased production, oligomerization and aggregation of amyloid-β (Aβ) peptides are hallmark pathologies of
Alzheimer’s disease (AD). Expressing familial AD mutations (amyloid precursor protein and/or presenilins mutations),
the Aβ-pathologies of AD has been recapitulated in animal models of AD. Very few primary cell culture-based
models of AD are available and they exhibit very weak Aβ-pathologies compared to what is seen in AD patients
and animal models of AD. CNS stem/progenitor cells are present in both embryonic and adult brains. They can be
isolated, grown as neurospheres and differentiated into neurons, astrocytes and oligodendrocytes. It is not yet
known whether CNS stem/progenitor cells can support the production of Aβ peptides in culture. In this report, we
have established Aβ-pathologies such as production, secretion, oligomerization and aggregation of Aβ peptides
utilizing neurosphere cultures to create a new cellular model of AD. These cultures were developed from E15
embryonic brains of transgenic mice carrying the Swedish mutations in humanized mouse APP cDNA and the
exon-9 deleted human presenilin 1 cDNA both regulated by mouse prion protein gene (Prnp) promoter. Results
demonstrated the expression of transgene transcripts, APPswe protein and its processed products only in transgene
positive neurosphere cultures. These cultures generate and secrete both Aβ40 and Aβ42 peptides into culture
medium at levels comparable to the Aβ load in the brain of AD patients and animal models of AD, and produce
pathogenic oligomers of Aβ peptides. The Aβ42/Aβ40 ratio in the medium of transgene positive neurosphere
cultures is higher than any known cellular models of AD. Conformation dependent immunocytochemistry
demonstrated the possible presence of intracellular and extracellular aggregation of Aβ peptides in neurosphere
cultures, which are also seen in AD brain and animal models of AD. Collectively, our neurosphere cultures provide
robust Aβ-pathologies of AD better than existing cellular model of Alzheimer’s disease.
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Alzheimer’s disease (AD) is a chronic, irreversible and
progressive neurodegenerative disease. AD is character-
ized by extracellular deposition of amyloid-β (Aβ) peptides
as senile plaques (Glenner and Wong 1984), intraneuronal
neurofibrillary tangles (NFT) (Kosik et al. 1986; Wood et al.
1986), astrogliosis (Rodriguez et al. 2009), microglial acti-
vation (Giri et al. 2003) and loss of synapses and neurons in* Correspondence: ranjitkgiri@hotmail.com
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in any medium, provided the original work is pthe brain (Selkoe 2002; Whitehouse et al. 1982). Genetic
linkage analysis of familial Alzheimer’s disease (FAD) iden-
tified amyloid precursor protein (APP) (Chartier-Harlin
et al. 1991; Goate et al. 1991; St George-Hyslop et al. 1987)
and presenilins i.e. PSEN1 (Citron et al. 1997; Sherrington
et al. 1995) and PSEN2 (Levy-Lahad et al. 1995) as the
causative genes in FAD. Mutations in these genes are linked
to increased Aβ formation, specifically the more fibrillo-
genic Aβ42 peptides (Borchelt et al. 1996b; Scheuner et al.
1996; Tomita et al. 1997), which led to the formulation of
the amyloid-β cascade hypothesis. The amyloid-β cascade
hypothesis states that Aβ production is the earliest eventn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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rodegeneration (Hardy and Allsop 1991; Sommer 2002).
Utilizing this hypothesis, transgenic animals were created
using human genes linked to FAD such as APP and
PSEN1. These transgenic animals show increased produc-
tion and deposition of Aβ peptides (senile plaques) and
memory impairments. However, the majority of such AD
animal models take upto a year to develop signs of disease
in the brain (Eimer and Vassar 2013; Youmans et al.
2012). Therefore, quicker, cheaper and reproducible alter-
native models were explored utilizing cell culture based
systems.
Various cancerous cell lines (Wang et al. 2000) and
primary cortical neurons (LeBlanc 1995; Lorenzo and
Yankner 1994; Takashima et al. 1993; Yankner et al.
1990) have been extensively utilized to study the toxic
effect of Aβ peptides. Cancerous cell lines with neuronal
origin (Borchelt et al. 1996b; Cai et al. 1993) and non-
neuronal origin (Citron et al. 1997; Haass et al. 1992)
that express FAD genes produce Aβ peptides and are
useful for the study of Aβ genesis, stability and intracel-
lular trafficking (Vassar et al. 1999; Wertkin et al. 1993).
However, these models are limited by their genetic in-
stability over multiple passages, their rapid growth rate
and their inability to model mature brain cell types.
Primary cell cultures expressing FAD genes may model
AD better in vitro, and thus warrant investigation.
Primary hippocampal cell cultures from transgenic ani-
mal models for AD express Aβ peptides endogenously
(Trinchese et al. 2004; Yun et al. 2007). However, these
cultures are difficult to maintain for more than 3 weeks
(Brewer and Torricelli 2007) and cannot be passaged.
Therefore, long-term experimentation and need for
repetition demands frequent tissue harvests when using
this system. Similarly, slice cultures cannot be maintained
for more than few weeks (De Simoni and Yu 2006). It has
been well documented that, CNS stem/progenitor cells
are present in both embryonic and adult brain. These cells
can be isolated and grown as neurospheres in substrate
free vessels over several passages like transformed cell
lines and maintain the properties of stem/progenitor cells
(Brustle et al. 1997; Ray and Gage 2006; Reynolds and
Weiss 1992; Uchida et al. 2000). Most importantly, neuro-
sphere cultures can be differentiated into major cell types
of an adult brain such as neurons, astrocytes and oli-
godendrocytes (Gritti et al. 1996; Ray and Gage 2006). Al-
though neural stem cells have been utilized to study the
effect of Aβ peptides, to our knowledge, there is no report
indicating the use of CNS stem/progenitor cells to model
beta amyloid pathology of AD in vitro.
In the present report, we have combined the trans-
genic and CNS stem/progenitor cell culture technologies
to develop a novel platform to model the pathological
processing of mutant human APPswe protein for Aβgenesis, oligomerization and aggregation, the initial events
of AD pathogenesis. Neurosphere cultures were estab-
lished from AD transgenic (APPswe,PSEN1dE9) mice
embryos. Neurosphere cultures positive for transgenes
(Tg+ve) express both transgenes at the mRNA level
and express humanized APP and its proteolytic products
including Aβ peptides. Analysis of Tg+ve neurosphere ly-
sates demonstrated the presence of both monomeric and
various oligomeric Aβ peptides similar to an 18-month
old Tg+ve mouse brain homogenate. Tg+ve neurosphere
cultures secrete a large amount of human Aβ peptides
that consist of Aβ40 and Aβ42 with a very high Aβ42/
Aβ40 ratio comparable to that of human AD brain
homogenates and more than any cellular model of AD.
Tg+ve culture supernatants also contain monomeric
and various pathogenic Aβ peptide oligomers (ranging
from 2-mer to 12-mer; the Aβ star oligomer). In addition,
conformation-dependent immunocytochemistry demon-
strated the presence of intracellular and extracellular Aβ
peptides within neurospheres. Thus, our results provide
compelling evidence for Aβ peptide genesis, secretion, oli-
gomerization and aggregation in Tg+ve neurosphere
cultures better than any existing cellular model of AD.
Materials and methods
Ethics statement
All experiments on animals were conducted in accord-
ance with guidelines approved by the committee for the
purpose of control and supervision of experiments on
animals (Regd. No. 464/a/CPCSEA). All animal proce-
dures were reviewed and approved by National Brain Re-
search Centre (NBRC) animal ethics committee (NBRC/
IAEC/2008/44).
Mice
B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J mice were obtained
from the Jackson Laboratory (Bar Harbor, Maine, USA)
and maintained as a mouse line in NBRC. Tg+ve mice
express APPswe (K670N and M671L) mutations in hu-
manized mouse APP cDNA and exon 9-deleted human
presenilin 1 (PSEN1dE9) cDNA under the control of the
mouse prion protein (Prnp) gene promoter. Both these
transgenes are integrated at a same locus resulting 50% of
litters are hemizygous for both APPswe and PSEN1dE9
transgenes and rest 50% as wild type controls from a cross
between hemizygous transgenics to wild type (Borchelt
et al. 1996a; Jankowsky et al. 2004).
Antibodies
Beta amyloid 1-16 monoclonal antibody (6E10), which is
specific for human APP and some of its proteolytic
products including Aβ peptides and anti-Aβ42 antibody
(BA3-9) specific for human Aβ42 were purchased
from Covance. Anti-nestin antibody was purchased from
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fibrillary acidic protein (GFAP) antibodies were purchased
from Santacruz, Sigma-Aldrich and DAKO respectively.
Secondary antibodies conjugated with HRP and Alexa-
fluorophores were purchased from Pierce and Invitrogen
respectively.
Isolation of DNA and genotyping
Total genomic DNA was isolated from the tail of mouse
during weaning using QIAamp DNA Mini kit (Qiagen).
Genomic DNA (1 μl) was used to amplify huAPPswe
and huPSEN1dE9 transgenes by polymerase chain reac-
tion (PCR). Primers for APP and PSEN1 transgenes were
purchased from Sigma. Primers sequences were obtained
from the Jackson Laboratory. PCR products were resol-
ved on 2% agarose gel and digital images of ethidium
bromide stained gels were captured using ChemiDoc
XRS+ gel doc system (BIO-RAD, USA).
Neurosphere isolation
Embryos from a wild type female mouse bred with a
hemizygous Tg(APPswe,PSEN1dE9) male mouse were
harvested on embryonic date 15 (E15) and neurosphere
(NS) cultures were isolated using earlier protocol (Giri
et al. 2006). Briefly, whole brain was isolated from each
embryo and triturated in 1 ml of neurobasal media supple-
mented with glutamax and antibiotics (all from Invitrogen,
USA) using filtered 200 μl tips to obtain homogeneous cell
suspension. Each cell suspension was diluted further to
10 ml using same media and filtered through 45 μm mesh
(Falcon, USA). The filtrates were centrifuged at 1000 rpm
(~100×g) for 5 min at room temperature (RT). Cell pellets
were gently triturated through filtered 200 μl tips and cul-
tured in T75 non-adherent culture flask (Nunc, USA) in
15 ml of complete neurobasal media (neurobasal media
supplemented with N2 supplement (1X), 2 mM Glutamax,
Penicillin-streptomycin mix (1X), 20 ng/ml of recombinant
huEGF, 10 ng/ml of recombinant huFGF-b (all from Invi-
trogen, USA) and 10 ng/ml of recombinant mouse LIF
(Chemicon, USA). After 2-3 days in culture, distinct cell
clumps were seen, collected and recultured in complete
neurobasal media. After every 3-4 days, 50% of media was
replaced with fresh complete neurobasal media. Usually,
distinct spheres of cells are visible by 4-7 days of culture.
These cultures took approximately one month of time to
grow sufficiently to warrant further passage. Neurospheres
were split at 1:3 ratios by triturating NS pellets. It is im-
portant to stress here that our culture system favors slower
growth than others but was developed to allow infection
by RML scrapie prions in NS cultures (Giri et al. 2006).
Neurosphere culture conditions that favor faster growth
are not infected with prions (Herva et al. 2010). Although
our cultures grow slowly, they are highly enriched
with nestin positive cells (CNS stem/progenitor cells)and generate neurons and astrocytes after differentiation
(data not shown). Therefore, in this report, we have
employed slow growing NS culture protocol to model Aβ
genesis, oligomerization and aggregation in vitro. Gen-
omic DNA from each NS line and mother’s tail were
isolated and genotyped for transgenes as mentioned
above. Nine NS lines have been established out of which,
NS1-4 are used extensively in this report. Furthermore,
two additional Tg-ve NS lines (NS6 and 7) were also used.
Isolation of RNA
Total RNA was isolated from each NS culture using
Trizol reagents (Invitrogen). Twenty microgram (μg) of
total RNA was treated with amplification grade and
RNase free DNase I (Invitrogen) as per manufacturer’s
protocol. Concentration of RNA was measured using
NanoVue Plus spectrophotometer (GE).
RT-PCR
Twenty-five nanogram of DNase I treated total RNA
from each NS line was reverse transcribed for cDNA
preparation. HuAPPswe, huPSEN1dE9 and GAPDH
transcripts were amplified by one-step reverse transcript-
ase PCR (RT-PCR) employing manufacturer’s protocol
(Qiagen). The following primers were used for RT-PCR:
APPswe, forward: 5′-TTCCCGTGAATGGAGAGAGTT
C-3′; reverse: 5′-ATGAACTTCATATCCTGAGTCATG
TCG-3′, PSEN1dE9, forward: 5′-GGTCCACTTCGTAT
GCTGGT-3′; reverse: 5′-TTCCCATTCCTCACTGAAC
C-3′. Primers for GAPDH were similar to that reported
earlier (Usenko et al. 2009). PCR products were resolved
using 2% agarose gel electrophoresis and digital images of
ethidium bromide stained DNA fragments were captured
in ChemiDoc XRS+ gel doc system.
Detection of huAPPswe protein in neurosphere lysates
Neurospheres were harvested at the end of each passage
by centrifuging the culture at 1000 rpm for 5 minutes at
room temperature. Neurosphere pellets were lysed in
RIPA buffer (150 mM NaCl; 10 mM Tris, pH 7.4; 0.5%
Triton-X 100; 0.5% sodium deoxycholate; 0.1% SDS and
1X protease inhibitor cocktail). Protein concentration
was determined by micro BCA protein assay kit (Pierce).
Sixty μg of total protein was size fractionated in 15%
Tris-Glycine polyacrylamide gel along with brain homo-
genates from 18-months old Tg+ve and Tg-ve control
mice. Aβ42 was used as an additional positive control.
Proteins were then transferred onto 0.2 μm PVDF mem-
branes. Blots were incubated for 10 min in boiling phos-
phate buffered saline (PBS) bath for epitope retrieval
(Ida et al. 1996; Swerdlow et al. 1986) followed by
immunoblotting with 1000-fold diluted 6E10 antibody.
The secondary antibody, anti-mouse IgG conjugated
with HRP was used to visualize the bands and by using
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X-ray film (Amersham). Time-lapse digital images were
also captured using ChemiDoc XRS+ gel doc system.
Digital images without saturation were used for densito-
metric and molecular weight analysis with ImageLab
(version 3.0) software.Detection of Aβ peptides in culture media
Culture media from Tg-ve and Tg+ve neurosphere lines
were collected at the end of each passage and after 4 days
of media change. Culture media were centrifuged at 100 × g
for 5 minutes at RT to sediment neurospheres, small cell
clumps and cell debris. Twenty-three milliliters (ml) of
culture medium were spin filtered in two batches in an
Amicon ultra 15 (or 8 ml of medium in Amicon ultra 4)
centrifugal filter (Millipore), which retain all proteins
above 3 kDa using manufacturer’s protocol. Retentates
were collected, aliquoted and stored at -80°C. Protein con-
centration, western blotting and immunoblotting with
6E10 antibody were perfomed as described earlier. To
differentiate Aβ40 and Aβ42 peptides in the Aβ pool
of culture supernatant, 60 μg of concentrated culture
supernatants along with 5 ng of each Aβ40 and Aβ42
peptides (as positive controls) were size fractionated
in 10% Bicine-Tris-Urea-polyacrylamide gel as descri-
bed earlier (Wiltfang et al. 1997). Western blotting
and detection of Aβ peptides was performed using
6E10 antibody. Imaging and densitometric analysis
were performed as described above.Immunocytochemistry
Neurospheres were triturated to obtain single cells
or small cell clumps preparation. Approximately,
100000 cells were seeded onto poly-D-lysine (PDL)
coated 24-well cover glass plates (Greiner) or onto
PDL coated precleaned 12 mm diameter glass cover-
slips. Cells were grown in complete medium for
3 days with a medium change after 1 day of seeding.
After removing the medium and three PBS washes,
cells were fixed in 4% formaldehyde (PFA) for 30 mi-
nutes at RT. Cells were washed thrice with PBS for
5 min each followed by permeabilization with 0.3%
Triton-X 100 in PBS for 5 minutes at RT. Cells were
blocked with 10% normal goat serum in washing
buffer (0.1% BSA, 0.05% NaN3 in 1X PBS) for 1 hour
at RT followed by overnight incubation with primary
antibodies at 4°C. Cells were then washed five times
(5 minutes each) followed by incubation with appro-
priate secondary antibodies conjugated with either
Alexa 488 or Alexa 594 fluorophores for 1 hour at
RT. After series of washes, cells were mounted in
prolong gold anti-fade reagent containing DAPI
(Molecular Probes).Conformation dependent immunocytochemistry (CDIC)
Under physiological conditions, Aβ peptides undergo
conformational changes to form β-sheet, which are not
efficiently reactive with 6E10 antibody (Rosen et al.
2010). Upon denaturation by formic acid (FA), the
epitope of Aβ peptides of various oligomers and con-
formers unfolds and binds efficiently with 6E10 anti-
body. Such mechanisms were exploited to detect the
possible presence of Aβ peptides within and outside the
cells in neurospheres. In neurosphere monolayer cultures,
cells were fixed and permeabilized. One group of NS cul-
tures from each line was treated with 70% FA for 1 hour
at RT and the other group left untreated. Immunostaining
was performed using 6E10 antibody as described earlier.
To detect intracellular and extracellular Aβ peptides
within neurospheres, fixation of neurospheres was per-
formed in 4% PFA overnight followed by serial passaging
through 10%, 20% and 30% sucrose in PBS. Neurospheres
were embedded in cryomedium and frozen in an ethanol-
dry ice bath. Ten μm thick frozen NS sections were
obtained using a cryotome (Leica). Immunodetection
of Aβ peptides with or without 70% FA treatment
was similar to that described above. In addition to 6E10,
an antibody specific for Aβ42 peptide was used to detect
Aβ42 peptides in NS sections exposed or not exposed to
formic acid.
Image acquisition and analysis
Images of all the samples within an experiment were
acquired during the same session by using identical
image acquisition settings for each fluorophore. For epi-
fluorescence imaging, digital images were acquired at
best focal plane using 40X planfluor objective lens and
Axiocam HR RGB camera in a ZEISS Axiovert 200 M
microscope supported by AxiovisionRel (version 4.6.3.0)
software. Densitometric analysis of images was per-
formed using ImageJ 1.42q software (NIH). Regions with
same area were drawn around the cell body of individual
non-overlapping cells and mean fluorescence intensity
(gray) value for individual cell was measured. After back-
ground subtraction, mean gray values were compared
between transgene negative and positive groups. For
confocal imaging of neurosphere sections, 63X oil, 12
bits multi-stack (at 0.5 μm interval) images were ac-
quired by LSM 510 confocal microscope (Zeiss). Max-
imum intensity projection of central three sections
was made and analyzed. For analysis, a fix sized re-
gion tool was made and mean gray values from 25
non-overlapping regions within the image containing
cell mass were obtained. Same region tool was used
on images captured from one experiment in one sitting.
Areas without cell mass were excluded. This approach
was adopted as some neurospheres had more hollow
space than others.
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Statistical analysis was performed by one-way ANOVA
when data passed normality and equal variance test using
Sigmastat 3.5 software. When data failed the above test, the
groups were compared by non-parametric Kruskal-Wallis
one-way ANOVA on ranks. In addition, non-parametric
Dunn’s method was employed to analyze pair-wise multiple
comparisons. T-test was also calculated using Excel (Micro-
soft). p-value ≤ 0.05 is considered statistically significant.
Results
Development of CNS stem/progenitor cells (neurosphere)
cultures from B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J mice
Embryonic day 15 (E15) brain cells isolated from B6C3-
Tg(APPswe,PSEN1dE9)85Dbo/J mice grew as balls of
cells termed as neurospheres (NS) within 4-5 days in
culture (Figure 1A). PCR assay for huAPPswe and huP-
SEN1dE9 transgenes demonstrated the amplification of a
350-bp and a 608-bp DNA fragments respectively from
NS1, NS3 and a Tg+ve mouse genomic DNA but not
from NS2 and NS4 lines (Figure 1B) showing that, NS1
and NS3 lines are Tg+ve, whereas NS2 and NS4 are
Tg-ve. Similar results were obtained at passages 0, 5 and
12 (data not shown). Neurosphere lines 5-9 were also geno-
typed. NS5, 8 and 9 were Tg+ve and NS6 and 7 were
Tg-ve (data not shown). Immunocytochemical analysis
of nestin on adherent cells from NS1-4 cultures indicated
the expression of nestin in a majority of cells (Figure 1C).Figure 1 Development of neurosphere (NS) cultures from B6C3-Tg(AP
embryos (E15) were isolated and grown in non-treated tissue culture flasks
huAPPswe (350-bp) and huPSEN1dE9 (608-bp) transgenes by PCR. (C) Expre
type analysis of nestin expression in NS1-NS4 lines is represented as histogCells without any antibody treatment (none) or treated
with secondary antibody (Sec. ab.), show minimal immu-
nosignal, indicating that both Tg-ve and Tg+ve NS lines
express nestin, the most commonly used marker for CNS
stem cells (Lendahl et al. 1990). Cell scoring analysis indi-
cates that more than 75% of cells are positive for nestin in
all the NS lines studied and no significant difference was
observed between Tg+ve and Tg-ve lines (ANOVA, n = 4,
F = 0.174, p = 0.912) (Figure 1D). When monolayer cultures
from NS lines were co-immunostained with nestin and
GFAP (a marker for glial cells), some cells are found to be
co-stained for nestin and GFAP (Figure 2A). Cell type ana-
lysis in three independent experiments indicates appro-
ximately 21.6 ± 1.46, 13.6 ± 10.1, 17.3 ± 3.66 and 8.7 ± 1.1
percent of total cells were positive for both nestin and GFAP
expression in NS2, NS4, NS1 and NS3 cultures respectively
(Figure 2B). In addition, when cells were co-immunostained
with nestin and β-tubulin III (a marker for young and ma-
ture neuron), approximately 19.3 ± 8.5, 16.4 ± 5.6, 8.7 ± 6.3
and 56.4 ± 4.6 percent of total cells are positive for both
nestin and β-tubulin III (Figure 3A & B). Collectively, our
NS cultures are enriched with CNS stem/progenitor cells.
APPswe and PSEN1dE9 transgene arrays are
transcriptionally active and large numbers of cells express
nestin and APP proteins in Tg+ve neurosphere lines
Reverse transcription and PCR analysis on DNase I
treated RNA isolated from NS1-4 cultures demonstratedPswe,PSEN1dE9)85Dbo/J E15 embryos. (A) Cells from four mouse
to form neurospheres (NS1-NS4). (B) Genotyping of NS1-NS4 for
ssion of nestin in NS1-4 lines by immunofluorocytochemistry. (D) Cell
rams of mean ± standard deviation (ANOVA, n = 4, F = 0.174, p = 0.912).
Figure 2 Expression of nestin and glial fibrillary acidic protein (GFAP) in neurosphere cultures. (A) Fixed monolayer culture of
neurosphere cultures, cells were immunostained with anti-nestin and anti-GFAP antibodies (for details see materials and methods). All the images
are displayed at the same intensity scale. Images show some nestin positive cells are also positive for GFAP (yellow arrowhead). (B) Cell type
analysis was performed by counting the cells positive for each marker manually, using ImageJ 1.42q software (NIH). Percent cells positive either
for nestin, GFAP or for both markers (co-stain) was plotted as histograms of mean + standard deviation of three independent experiments. No
significant difference is found between GFAP stained cell populations among NS1, NS2, NS3 and NS4 lines regardless of the presence of transgenes.
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cific for huAPPswe and huPSEN1dE9 transcripts re-
spectively in NS1 and NS3 lines but not in NS2 and NS4lines (Figure 4A). GAPDH mRNA expression was similar
in all NS cultures indicating the equal loading of RNA
from all NS lines. An RT-minus control PCR on DNase I
Figure 3 Expression of nestin and β-tubulin III in NS cultures. (A) Monolayer of cells was cultured as described earlier. Immunostaining with
nestin and β-tubulin III antibodies, image acquisition, analysis and display are similar to Figure 2. Images demonstrate that some cells are positive
for both nestin and β-tubulin III (yellow arrowheads). (B) Percent cells positive either for nestin, β-tubulin III or for both (co-stain) was plotted as
histograms of mean + standard deviation from 6 images from two independent data sets. Significant increase in nestin and β-tubulin III co-stain
cells is observed in NS3 line. *indicates p≤ 0.05 when compared with other neurospheres and **indicates p≤ 0.05 when compared with NS1
co-stain cells.
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Figure 4 Transgene positive neurosphere cultures transcribe both the transgenes, express humanized APP and co-express nestin. (A)
Detection of huAPPswe (233-bp) and huPSEN1dE9 (141-bp) transcripts in neurosphere lines by RT-PCR analysis. A 599-bp GAPDH fragment was
amplified to validate equal RNA loading in all NS lines. (B) Immunofluorocytochemistry of nestin shows the majority of cells in all neurosphere
lines express nestin. (C) Fluorescence images show expression of huAPPswe protein only in Tg+ve neurospheres using 6E10 antibody. Nuclei
were stained with DAPI. (D) Fluorescence intensity from individual cells was derived and intensity above secondary antibody signal was
considered as positive. Percentage of cells positive for each antibody from three independent experiments is demonstrated as histograms of
mean ± standard deviation.
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(data not shown) suggesting the APPswe and PSEN1dE9
amplified products in NS1 and NS3 lines came from
mRNA and not from DNA. To study nestin and APP
co-expressing cells in Tg+ve NS cultures, we utilized
immunofluorocytochemistry along with cell count
analysis. Approximately, 77 ± 20, 83 ± 15, 78 ± 20 and
75 ± 11 percent of total cells analyzed from three inde-
pendent experiments express nestin in NS2, NS4, NS1
and NS3 cultures respectively (Figure 4B & D). Immu-
nostaining analysis (n = 3 independent experiments)
with 6E10 antibody showed only 1.8 ± 2.2, 7 ± 3.3 in
Tg-ve NS2 and NS4 lines respectively but 54 ± 17.12
and 75 ± 13.6 percent cells positive for APP expression
in Tg+ve NS1 and NS3 cultures respectively (Figure 4C
& D). Since nestin as well as APP expression is seen
in more than 50% of total cells in Tg+ve NS cultures,
it is postulated that nestin positive cells also express
APP protein. Collectively, promoters for both the
transgenes are active in neural stem cells and express
APP protein in Tg+ve NS cultures, a prerequisite condi-
tion for its proteolytic processing towards Aβ peptide
formation.Cells in Transgene positive neurosphere lines co-express
human APP protein and β-tubulin III or GFAP
Immunofluorocytochemical analysis of β-tubulin III
expression demonstrates few cells are positive in Tg-ve
NS2 and NS4 cultures and as expected, these cells are
negative for APP expression. In Tg+ve NS1 and NS3
cultures, β-tubulin III positive cells co-localize with APP
expression (Figure 5A). Cell type analysis of these cells
from three independent experiments indicates almost all
the β-tubulin III positive cells in NS1 (10.3 ± 5.3%) and
NS3 (45.4 ± 6.8%) cultures also express APP protein
(Figure 5B). When cells were co-immunostained with
APP and GFAP, the results show 13.01 ± 2.3% and 11 ±
4.1% of total cells express GFAP in Tg-ve NS2 and
NS4 cultures, and are not co-stained for APP expression
(Figure 6B). In Tg+ve NS cultures, approximately, 14.8 ±
2.4% and 9.55 ± 5.5% cells are positive for GFAP expres-
sion in NS1 and NS3 respectively (Figure 6A & B). Cell
type analysis shows that the majority of them also express
APP (Figure 6B). Thus, β-tubulin III +ve neuronal and
GFAP +ve astroglial progenitors are present in our NS
cultures and express APP protein in Tg+ve neurosphere
cultures.
Figure 5 Expression of APP and β-tubulin III proteins in neurosphere monolayer cultures. (A) Triturated cells from NS cultures were grown
on PDL coated optical cover-glass plates or glass coverslips for 3 days in complete media. Immunostaining with 6E10 (specific for human APP)
and β-tubulin III antibodies, image acquisition, analysis and display are similar to Figure 2. Images demonstrate presence of cells positive for both
APP and β-tubulin III in NS1 and NS3 (yellow arrowheads). (B) Percent cells positive either for APP or β-tubulin III or both (co-stain) are plotted as
histograms of mean + standard deviation from three independent data sets. Significantly more APP and β-tubulin III co-stained cells are observed
in NS3 line. *indicates p≤ 0.05 when compared with other neurospheres and **indicates p≤ 0.05 when compared with NS1 co-stained cells.
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Figure 6 Expression of APP and GFAP proteins in neurosphere monolayer cultures. (A) Immunostaining of APP and GFAP on cell
monolayers were performed as described earlier. Images demonstrate that some cells are positive for both APP and GFAP (yellow arrowheads) in
Tg+ve NS lines. (B) Percent cells positive either for APP, GFAP or both (co-stain) are plotted as histograms of mean + standard deviation from four
independent experiments.
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APPswe protein and generate amyloid-β (Aβ) monomers
and pathogenic oligomers
Western blot analysis of NS lysates from NS1-4 lines
with 6E10 antibody clearly demonstrated the expression
of full length huAPPswe (90.2 kDa) and its processedpeptides in NS1, NS3 and Tg+ve mouse brain homogen-
ate (positive control) but not in NS2, NS4 and Tg-ve
mouse brain homogenate (negative control). A fragment
close to 12 kDa was seen only in Tg+ve NS lines and in
Tg+ve MBH, which likely represents the C99 fragment
(APP β-carboxy-terminal fragment). Interestingly, additional
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http://www.springerplus.com/content/3/1/161bands ranging from 10.1 kDa to 62.3 kDa were also seen
exclusively in Tg+ve NS lines and Tg+ve MBH. Molecular
weight analysis of these bands corresponds to 2 to 14-
mers of Aβ oligomers (Figure 7). In addition, monomeric
Aβ peptides were detected only in Tg+ve but not in Tg-ve
NS lysates. However, monomeric and oligomeric Aβ pep-
tides intensities are weaker in Tg+ve NS lysates than in
Tg+ve MBH. It is important to mention here that Tg+ve
MBH contains both extracellular and intracellular Aβ
peptides whereas NS lysates contain mostly intracellular
Aβ peptides. Collectively, Tg+ve NS cultures express APP
and its proteolytic peptides including Aβ peptides in
monomeric and pathogenic oligomeric forms.
Transgene positive neurosphere cultures secrete large
amount of Aβ peptides into culture media
Since Aβ peptide levels were lower in Tg+ve NS lysates
than Tg+ve MBH and Aβ peptides are deposited as
senile plaques in the extracellular matrix of AD brain,
we reasoned that most of the Aβ peptides might be
secreted into culture media. Western blot analysis of
concentrated NS culture supernatants demonstrated the
presence of human Aβ peptides only from NS1 and NS3Figure 7 Expression of huAPP and its proteolytic fragments in Tg+ve
lysate was western blotted onto 0.2 μm PVDF membrane and immunoblot
presence of huAPPswe full-length protein only in NS1, NS3 and 18 month
NS4 and 18 m old Tg-ve MBH. Monomeric and 2 days old oligomeric Aβ42
between Tg+ve neurosphere lysates and 18 m old Tg+ve MBH but not pre
weight analysis indicates these bands could represent Aβ monomers to variou
with GAPDH antibody to verify differences in protein loading. Data representscultures (Figure 8A). Oligomers (3-9-mer) and large
oligomers of Aβ peptides are also seen in NS1 and NS3
culture supernatants (Figure 8A). A longer electrophor-
esis of the same samples in a separate polyacrylamide
gel exhibited the presence of 10 and 12-mer Aβ oligo-
mers in NS1 and NS3 culture supernatants (Figure 8B).
Using known amount of Aβ42 peptides as standards,
densitometric analysis of monomeric Aβ peptides in
NS1 and NS3 culture supernatant was found to be 173 ±
96 ng and 128 ± 42 ng per milligram of total protein
respectively (n = 4 independent experiments) (Figure 8C).
In addition, the densitometric analysis of total oligomeric
fractions (ranging from 2-mer to large oligomers) indi-
cated NS1 culture supernatant has approximately 2.5-fold
more Aβ oligomeric forms than NS3 culture supernatant
(Figure 8D). Taken together, Tg+ve neurosphere cultures
secrete both monomeric and wide range of Aβ oligomeric
isoforms, a signature of AD pathology (Lesne et al. 2013).
Next we wanted to resolve monomeric Aβ pool to iden-
tify various Aβ peptides secreted into the culture medium.
Results showed the Aβ40 and Aβ42 peptides are only pro-
duced by Tg+ve (NS1 and NS3) but not by Tg-ve (NS2
and NS4) NS lines (Figure 9A). Densitometric analysis ofneurosphere lines. Sixty microgram of total protein from each NS
ted with 6E10 antibody after HIER. Images clearly indicate the
(18 m) old Tg+ve mouse brain homogenate (MBH) but not in NS2,
peptides were taken as positive controls. *indicates bands in common
sent in Tg-ve neurosphere lysates and 18 m old Tg-ve MBH. Molecular
s oligomers as mentioned. Membranes were stripped and immunoblotted
four independent experiments.
Figure 8 Detection of human Aβ peptides in neurosphere culture supernatants. (A) Sixty microgram of total protein from 80 to 100-fold
concentrated neurosphere culture supernatant were size fractionated in Tris-Glycine-SDS-PAGE along with monomeric and oligomeric Aβ42
peptides as positive controls, transferred onto 0.2 μm PVDF membrane and immunoblotted with 6E10 antibody after heat induced epitope
retrieval (HIER). Chemiluminescence digital images show the presence of Aβ monomers and various oligomeric Aβ peptides only in Tg+ve but
not in Tg-ve neurosphere culture supernatants. Molecular weight analysis of these bands was compatible with the oligomers indicated. (B) A
longer electrophoresis of the same samples resolved high molecular weight oligomers as potential Aβ 10-mers and 12-mers. (C) Densitometric
analysis was used to measure the monomeric Aβ peptides in NS culture supernatants employing known amounts of Aβ42 as standards. (D)
Densitometric analysis of Aβ oligomers (2-mer to 64 kDa) is presented as histograms of mean + standard deviation. Data represents four independent
experiments. LO = Large Oligomer.
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indicated Aβ42/Aβ40 ratio as 0.875 ± 0.336 and 0.989 ±
0.487 for NS1 and NS3 respectively (Figure 9C). Similar to
our previous result, NS1 culture supernatants contain
approximately 2.2-fold more oligomeric Aβ peptides than
NS3 culture supernatants (Figure 9B & D).
Cells in transgene positive neurosphere lines have
intracellular Aβ peptides
Western blot analysis of NS lysates indicated the
presence of intracellular localization of Aβ peptides. To
validate intracellular pool of Aβ peptides, we utilized
conformation dependent interaction of Aβ peptides with
6E10 antibody. However, 6E10 antibody interacts with
full length human APP as well as human Aβ peptides
which requires epitope retrieval (Rosen et al. 2010). To
dissect the effect of epitope retrieval on full-length APP
and Aβ peptides by 6E10 antibody, we performed western
blot analysis of Tg+ve mouse brain homogenate using
6E10 antibody with or without heat induced epitope re-
trieval (HIER) (Ida et al. 1996). The densitometric analysis
of APP, Aβ and GAPDH bands from both the conditions
indicates HIER induced increased Aβ signal is 20-fold
higher than HIER induced increased APP signal and 12-
fold higher than HIER induced increased GAPDH signal(Additional file 1: Figure S1). Thus, Aβ peptides require
more epitope retrieval than full length APP for its inter-
action with 6E10 antibody. Similarly, formic acid (FA)
treatment has been found to be essential for the detection
of aggregated intraneuronal Aβ peptides in the brain sec-
tion of a mouse model of AD (Christensen et al. 2009)
suggesting Aβ epitopes are hidden within aggregated Aβ
structures. Immunofluorescent staining of adherent cells
from NS cultures demonstrated significant higher im-
munosignal towards 6E10 in Tg+ve than Tg-ve NS lines
without FA treatment (Figure 10A, upper panel & 10B).
However, after FA treatment, Tg+ve cells showed dramatic
increased immunosignal over untreated counterparts,
whereas, as expected, Tg-ve cells showed marginal in-
crease (Figure 10A, lower panel & 10B). Thus, increased
immunosignal in Tg+ve neurosphere cultures to epitope
retrieval might represents intracellular monomeric and
oligomeric Aβ peptides.
Accumulation of extracellular and intracellular Aβ
peptides within transgenic positive neurospheres
Since our neurosphere cultures are much slower growers
(split 1 to 3 every 30 to 40 days) than cancerous cell
lines and neurospheres under most other culture con-
ditions (split 1 to 4 once a week) (Orr et al. 2012),
Figure 9 Amyloid-β peptides in Tg+ve neurosphere culture supernatants contain Aβ40 and Aβ42 peptides. (A) Sixty microgram of total
protein from concentrated neurosphere culture supernatants were size fractionated in 10% Tris-Bicine-Urea-SDS-PAGE along with 5 ng of
monomeric Aβ40 and Aβ42 peptides, followed by immunoblotting with 6E10 antibody after HIER. Tg+ve NS1 and NS3 neurosphere culture
supernatants contain both Aβ40 and Aβ42 peptides but they are not seen in Tg-ve neurosphere culture supernatants. (B) Images from a shorter
exposure show large oligomeric Aβ levels are higher in NS1 than NS3 culture supernatants. (C) Densitometric analysis of Aβ40 and Aβ42 peptide
bands indicates the ratio of Aβ42/Aβ40 in NS1 and NS3 culture supernatants as 0.875 ± 0.336 and 0.989 ± 0.487 respectively. (D) Densitometric
analysis of large Aβ oligomers is presented as histogram of mean + standard deviation from four separate experiments.
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neurospheres. NS sections immunostained with 6E10 anti-
body and with or without 70% FA treatment showed
significant increased immunoreactivity in Tg+ve than
Tg-ve NS lines (ANOVA, non parametric, H = 817.827,
P < 0.001, n = 6 neurosphere sections) (Figure 11A & B).
Moreover, FA treated Tg+ve NS sections, demonstrated
significant increased immunoreactivity over untreated
counterparts (Figure 11A & B). Immunosignals of puncta
were seen within neurosphere sections but outside cellular
structures raising the possibility of extracellular aggrega-
tion of amyloid-β peptides. In order to address the specifi-
city of 6E10 antibody, NS sections were immunostained
with an antibody specific for human Aβ42. Tg+ve NS sec-
tions exhibited very high immunostaining in FA treated
sections in comparison to untreated Tg+ve NS sections
(Figure 11C & D). Small aggregates were seen outside
the cellular bodies in FA treated Tg+ve NS sections
(Figure 11C, middle and right panel, red arrowheads). In
addition, aggregates of Aβ42 immunosignal in the form of
puncta are also seen within the cells of FA treated Tg+ve
NS sections (Figure 11C, right panel, purple arrowheads).
Collectively, our results indicate intracellular and
extracellular aggregation of Aβ peptides in Tg+ve neuro-
spheres lines.Discussion
In this study, we report a novel way to model the genet-
ics of familial Alzheimer’s disease (FAD) using mouse
neurosphere cultures expressing APPswe and PSEN1dE9
mutations of FAD. Using these culture systems we
observed the synthesis, secretion, oligomerization and
aggregation of human beta amyloid peptides (Aβ40 and
Aβ42) better than existing cellular models of AD and
comparable to transgenic mouse models of AD (Citron
et al. 1997; Oakley et al. 2006).
Several cell culture-based systems from human or ro-
dent, primary or cell lines of neuronal or non-neuronal
have been reported. Primary neuronal cultures were pre-
ferred over transformed cell lines for two major reasons a)
APP expression was thought to be restricted to mature
neurons, and b) genomic instability in cancerous cell lines.
Although, primary neuronal cultures from transgenic ani-
mal models for AD produced both Aβ40 and Aβ42 pep-
tides but survived only for 12 days (Trinchese et al. 2004)
or up to 20 weeks (Yun et al. 2007). Recently, induced
pluripotent stem cells (iPSCs) derived from fibroblast of
FAD patients have been used to model amyloid-β genesis
in vitro (Yagi et al. 2011). A similar model was developed
using fibroblasts from two sporadic and two familial AD
patients. Both the FAD lines and one of two lines from
Figure 10 Detection of intracellular Aβ peptides by CDIC. (A) Fixed and permeabilized adherent cells from neurosphere cultures were either
treated with formic acid (FA) or left untreated followed by immunostaining with 6E10 antibody. Detection was done using Alexa 594 labeled
secondary antibody. (B) Quantification of fluorescence intensity indicates that Tg+ve NS lines show significant increased signal over Tg-ve lines in
both the treatments. FA treatment significantly increased signal in Tg+ve NS lines (NS1 and NS3) compared to non-treated counterparts suggesting
the possible presence of intracellular Aβ peptides (non-parametric one-way ANOVA, n = 3, H = 1909.061 and p < 0.001).
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over wild type cells (Israel et al. 2012). However, the level
of Aβ42 is not reported, which increases over Aβ40 in AD
patients. In addition, these models utilize transduction of
fibroblast with retroviruses encoding OCT4, SOX2, KLF4
and c-MYC, which are by and large cancerous and form
teratomas (Israel et al. 2012). Nevertheless, the advantage
of studying patients-derived lines is to determine the in-
fluence of varied genetic backgrounds on AD pathology
in vitro. However, in this report, the role of FAD muta-
tions on mouse neurosphere cultures can be studied on a
defined genetic background and these cultures grow con-
tinuously for more than 15 passages (at least a year). Thus,
our neurosphere cultures offer the advantage of both cell
lines and primary cultures.
Unlike iPSC-based culture systems, none of the primary
and cancerous cellular model of AD addressed more than
one cell type. In this study, neurosphere cultures contain a
high percentage of nestin positive CNS stem cells/pro-
genitor cells as reported earlier (Lendahl et al. 1990).
Some nestin positive cells express either GFAP (marker
for astrocytes) or β-tubulin III (a marker for young and
mature neuron) proteins. Cells co-expressing nestin and
GFAP has been reported as astroglial progenitor cells(Wei et al. 2002; Draberova et al. 2008). Radial glia cells of
human fetal telencephalon and post-natal rat also express
GFAP and nestin along with GLAST (Zecevic 2004;
Gubert et al. 2009). Thus, nestin and GFAP co-expressing
cells in neurosphere cultures suggests the presence of
astroglial progenitor and/or radial glia cells. However, we
have not tested other markers of radial glial cells such as
GLAST and BLBP. Furthermore, co-expression of nestin
and neuronal markers, NeuN (Wei et al. 2002) and
β-tubulin III (Draberova et al. 2008) has been reported as
an indicator of neuronal precursor cells. Therefore, neuro-
sphere cultures in this study contain CNS stem, glial pro-
genitor and neuronal progenitor cells, which may provide
additional options to study a variety of differentiated brain
cells in the future. Differentiation of our neurosphere
cultures produce MAP2+ and β-tubulin III+ neurons
and GFAP+ astrocytes without nestin expression (data
not shown).
It has been reported that, Aβ peptides are derived
from the proteolytic cleavage of APP. Our results from
neurosphere lysates (Figure 7) show the expression of
full-length humanized APPswe transgene protein and its
processed peptides in Tg+ve but not in Tg-ve NS cul-
tures. Presence of C99 peptides suggests the expression
Figure 11 Detection of Aβ peptides within neurospheres by CDIC. (A) Neurosphere sections (10 μm thick) were either treated with FA or
left untreated, then immunostained with 6E10 antibody. Confocal images were captured using similar exposure settings and displayed with
similar intensity scale. White arrowheads indicate the presence of puncta within neurosphere sections. (B) Fluorescence intensities were
measured and are plotted as histograms of mean + SD of six neurospheres sections. (C) Neurosphere sections were also immunostained with an
anti-Aβ42 antibody with similar pretreatments. Red and purple arrowheads indicate the presence of puncta outside and within the cells respectively.
(D) Intensity of Aβ42 fluorescence was measured from six independent neurosphere sections and the mean + SD is plotted as histograms. Student’s
T-test was performed. p value≤ 0.05 indicate significant difference between the groups.
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lytic activity on transgene-encoded APPswe protein as
reported earlier (Vassar et al. 1999). Presence of Aβ pep-
tides also suggests the proteolysis of APP by γ-secretase
of which PSEN1 is one of the components. Thus, neuro-
sphere culture system has necessary cellular machineries
to produce Aβ peptides from APP.
Aβ peptides are the major insoluble component of the
senile plaques in AD and are elevated in AD brain. In
AD patients, total Aβ load ranged from 7.8 ng/mg
(Wang et al. 1999), 39.824 ng/mg (Ingelsson et al. 2004)
to 171 ng/mg (Lue et al. 1999) of total brain proteins.
Primary hippocampal cell cultures expressing human
APP and PSEN1 mutations produced only 3.28 ng of Aβ
peptides from each milligram of total culture super-
natant proteins (Trinchese et al. 2004). Purified neurons
differentiated from iPSC lines isolated from two FAD
patients and one of two sporadic patients secreted only
0.3 ng of Aβ40/mg of lysate (Israel et al. 2012). Trans-
genic mice expressing five familial Alzheimer’s disease
mutations (5XFAD; Tg6799) have been reported to pro-
duce Aβ peptides approximately 205 ng/mg and 160 ng/mg
of total brain lysate protein in female and male mice
respectively at 12 months of age (Oakley et al. 2006).
In present study, Tg+ve neurosphere cultures produce
monomeric Aβ peptides of 172 ± 96 ng/mg and 128 ±42 ng/mg of total culture supernatant proteins in
NS1 and NS3 neurosphere cultures respectively.
Taken together, these neurosphere cultures secrete extra-
cellular Aβ peptides comparable to the concentration of
Aβ peptides in human AD brain, 5XFAD mouse brain and
much higher level than iPSC and other cellular models
of AD.
Aβ40 and Aβ42 are most prevalent Aβ peptides in
AD. Tg+ve neurosphere lines secrete both Aβ40 and
Aβ42 with Aβ40 amount more than Aβ42. A similar
observation has been made in blood plasma and cere-
brospinal fluid from AD patients (Bibl et al. 2006) sug-
gesting Aβ40 might be produced more or secreted more
efficiently than Aβ42. It has been reported that patho-
genic Aβ40 and Aβ42 peptides are produced by neurons,
astrocytes (LeBlanc et al. 1997) and oligodendrocytes
(Skaper et al. 2009) in AD indicating the expression of
APP not only restricted to neurons but also in astrocytes
and oligodendrocytes. Furthermore, earlier reports also
suggest physiological expression of APP in two-cell em-
bryo, preimplanted and postimplanted embryos, and in
the developing neural tube where early neural stem cells
are formed (Fisher et al. 1991). Therefore, neural stem/
progenitor cells of developing and adult brain might be
contributing Aβ peptides to total brain Aβ load in
AD patients as well as in the animal model of AD. In
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expressed in neuron, astrocytes, oligodendrocytes and
neural stem cells of adult brain. Therefore, utilization
of Prnp promoter to express FAD genes is a better
choice not only for neurons but other brain cells
including neural stem/progenitor cells.
Aβ42/Aβ40 ratio has been found to be higher in cells
or mice expressing both APP and mutant PSEN1 gene than
expressing wild type APP alone (Borchelt et al. 1996b;
Tomita et al. 1997). In addition, AD patients with PSEN1/
PSEN2-linked mutations exhibited increased Aβ42/Aβ40
ratio than unaffected individuals and this elevated ratio is
considered as a pathological feature of AD (Scheuner et al.
1996). Aβ42/Aβ40 ratio in the culture supernatant of pri-
mary hippocampal neurons isolated from mice expressing
both human APP mutations (K670N: M671L) and human
PSEN1 mutation (M146L) is 0.302 (Trinchese et al. 2004).
Differentiated neurons from iPSC-based model of FAD pa-
tients harboring a mutation in PSEN1 (A246E) or PSEN2
(N141I) genes exhibit Aβ42/Aβ40 ratio as 0.2 (Yagi et al.
2011). Mice expressing APPswe and PSEN1dE9 mutations
(similar to present model) exhibited Aβ42/Aβ40 ratio of
1.2 (Jankowsky et al. 2004). Aβ42/Aβ40 ratio in 5XFAD
mouse model of AD, have been found to be 1.8 in females
and 2.75 in males (Oakley et al. 2006). Such high Aβ42/
Aβ40 ratio has been associated with the neurodegeneration
seen in this mouse model of AD independent of tauopathy
indicating high Aβ42/Aβ40 ratio is an important parameter
in modeling beta amyloid pathology of AD in vitro. In this
study, we demonstrated Aβ42/Aβ40 ratio of 0.875 ± 0.336
and 0.989 ± 0.487 in NS1 and NS3 culture supernatants
respectively. To our knowledge, there is no other cellular
model of AD available with such a high Aβ42/Aβ40 ratio.
Oligomerization of Aβ peptides has been reported in
Tg2576 mouse brain homogenates and their contribu-
tion to cognitive deficits independent of plaque load or
neuronal loss, suggesting one or more oligomeric forms
of Aβ peptides are pathogenic (Cheng et al. 2007; Cleary
et al. 2005; Lesne et al. 2006, 2013). In this study, we
observed oligomers of Aβ peptides ranging from 2-mer
to 14-mer in Tg+ve but not in Tg-ve NS lysates and 2-
12-mer in Tg+ve culture supernatants. Our results also
demonstrate the presence of Aβ-12mer (Aβ*56) peptides
in Tg+ve NS culture supernatants. Very recently Aβ tri-
mers, which are thought to be the fundamental amyloid-
β assembly unit of Aβ*56, have been reported in young
AD mice as well as in 10 years old children (Lesne et al.
2013). In this report we have also observed the presence
of both Aβ trimers and Aβ*56 peptides in Tg+ve neuro-
sphere cultures. Therefore, we want to speculate that the
pathogenic Aβ production and oligomerization might be
happening inside and outside the cells and even in CNS
stem or progenitor cells during the early stage of life in
AD patients.Furthermore, presence of Aβ peptides in Tg+ve NS
lysates suggest the presence of intracellular Aβ peptides
which is well supported by the results from conform-
ation dependent immunocytochemistry on cells and NS
sections. Intraneuronal accumulation of Aβ peptide has
been associated with cellular pathology related to cogni-
tive malfunction in AD brain (Takahashi et al. 2002;
Walsh et al. 2000) and in the brain from mouse models
of AD (Eimer and Vassar 2013; Oddo et al. 2006; Wirths
et al. 2001; Youmans et al. 2012). Neurotoxic effect
(Deshpande et al. 2006) and synaptotoxic effect (Walsh
et al. 2002) of oligomeric forms of Aβ have also been
reported. Our neurosphere cultures continued to grow
and showed no sign of cytotoxicity. This could be due to
continuous addition of mitotic factors like EGF, FGF and
LIF in the culture medium. Similar to our results, no dif-
ference in population doubling was observed between wild
type and Tg2576 derived secondary neurospheres, equiva-
lent to passage 1 in this study (Baldassarro et al. 2013).
In addition, the amount of Aβ monomers and oligomers
in NS1 is greater than in NS3 culture supernatant in all ex-
periments. We determined that NS1 neurosphere line is
female and NS3 is male (for genotyping result, see
Additional file 2: Figure S2). It has been shown that female
APP/PSEN1 mice build up more amyloid deposits than age
matched male mice (Wang et al. 2003; Sierksma et al.
2013). Epidemiological studies also suggest an increased
risk for AD among females compared to age-matched
males (Andersen et al. 1999). Collectively, our neurosphere
culture manifested higher Aβ load, high Aβ42/Aβ40 ratio
and gender bias towards Aβ synthesis and oligomerization,
which parallels the situation in AD patients and in animal
models that express APPswe and PSEN1dE9 mutations.
The effect of Aβ peptides on neural progenitors cells
(NPC) is controversial. Proliferation and survival of NPC
in the dentate gyrus of the hippocampus was reduced in
mice transgenic for FAD mutant APP. Reduced neuronal
cell survival was seen after Aβ treatment of cultured
human and rodent NPC (Haughey et al. 2002). Uchida
et al. have also reported acceleration of differentiation
followed by death in Aβ treated neural stem/progenitor
cells (Uchida et al. 2000). In contrast to these reports,
increased hippocampal neurogenesis in AD patients and
Aβ treated neural stem cell cultures from striatum and
hippocampus have been reported (Jin et al. 2004; Lopez-
Toledano and Shelanski 2004). Most of these reports
employed exogenous Aβ peptides treatments. However,
our neurosphere cultures secrete Aβ peptides endogen-
ously, ranging from monomeric to various pathogenic
oligomeric forms. Whether CNS stem/progenitor cells-
enriched neurosphere cultures are affected by being
bathed in Aβ peptides is not known. Our future studies
will address such questions using these Aβ peptide pro-
ducing NS cultures.
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Our results for the first time report that CNS stem/pro-
genitor cell-enriched neurosphere cultures express ma-
jorities of the Aβ peptide pathologies that are seen in
AD patients and animal models of AD. The advantages
our neurosphere cultures offer over existing cellular
models are 1) these cultures offer both primary and can-
cerous cell benefits, and contain CNS stem/progenitor
like cells, which can differentiate towards mature brain
cells like neurons and astrocytes that are not possible in
transformed cell lines, 2) synthesize and secrete both Aβ
peptides, 3) demonstrate high Aβ42/Aβ40 ratio, 4) pro-
duce pathogenic Aβ peptide oligomerization (including
toxic Aβ 12-mer; Aβ*56 peptide) at a level comparable
to the animal models of AD and much higher than exist-
ing cellular models of AD, including iPSC based models
of AD and 5) demonstrate intracellular and extracellular
aggregation of Aβ peptides. Having such strong Aβ pep-
tide pathologies, differentiated cells from these cultures
in future will advance our understanding on cellular
and molecular changes in response to endogenously
produced Aβ peptides and possible therapeutic studies
to decrease beta amyloid synthesis and aggregation
within cells.Additional files
Additional file 1: Figure S1. Effect of heat induced epitope retrieval
(HIER) on APP, GAPDH and Aβ peptides. (A) Sixty μg of total protein from
a Tg+ve and Tg-ve mouse brain homogenate was size fractionated in
16% Tris-Glycine-SDS-PAGE along with 25 ng of Aβ42 monomeric
peptides. Proteins were transferred onto 0.2 μm nitrocellulose membrane
and immunoblotted with 6E10 antibody with or without HIER. Digital
images were captured using a ChemiDoc XRS+gel doc system (BIO-RAD,
USA). Images from blots with or without HIER treatment are displayed
with identical image intensity scale. After the completion of imaging, the
blots were stripped and immunoblotted with an antibody specific for
GAPDH. (B) Densitometric analysis of bands corresponding to APP (full
length), Aβ monomers and GAPDH were made using ImageLab (version
3.0) software. Results indicate HIER increased the APP, GAPDH and Aβ42
signal by 5.57, 10.38 and 120.39 fold respectively than without HIER
suggesting Aβ peptides require HIER treatment approximately 21-fold
more than APP and 12-fold more than GAPDH. HMW = High molecular
weight, FL = full length.
Additional file 2: Figure S2. Detection of male specific gene, SRY by
polymerase chain reaction (PCR). Genomic DNA was isolated from
neurosphere cultures and also from a male mouse. A DNA PCR was used
to amplify SRY gene (specific for maleness in mouse) using forward
primer as 5′-AGGCACAAGTTGGCCCAGCA-3′ and reverse primer as 5′-
TGTGGGTTCCTGTCCCACTGCA-3′. Result indicates a band of 269 bp was
amplified from the genomic DNA of NS3 and a male mouse but not
from NS2, NS4 and NS1. Thus, NS3 neurosphere is a male neurosphere
whereas NS1, NS2 and NS4 are female neurospheres. Mo = Mouse.Abbreviations
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precursor protein; PSEN: Presenilin; Aβ: Amyloid beta; CNS: Central nervous
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CDIC: Conformation dependent immunocytochemistry; HIER: Heat induced
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